The "EFFECTIVE Act" aims to enhance the scrutiny by the Food and Drug Administration (FDA) of clinical trials before approving medical products. It requires the FDA to thoroughly evaluate the impact and significance of clinical trials in determining a product's approval. This bill seeks to ensure that rigorous assessments are conducted prior to endorsing new medical treatments, potentially leading to increased safety and effectiveness of approved products.
2023-03-03: Introduced in House
2023-03-03: Referred to the House Committee on Energy and Commerce.
2023-03-10: Referred to the Subcommittee on Health.
Contribute Your Insights: Add a Unique Perspective to Political Bills. Your Contribution will be Featured Below the Primary Bill, Ordered by Date Added.
No Reviews found ..